Published in BMJ Open on June 20, 2013
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis. BMC Med (2016) 0.83
TB Summit 2014: prevention, diagnosis, and treatment of tuberculosis-a meeting report of a Euroscicon conference. Virulence (2014) 0.79
Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs. Br Med Bull (2016) 0.77
Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon conference 2013. Virulence (2013) 0.77
Tackling tuberculosis: Insights from an international TB Summit in London. Virulence (2015) 0.76
DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities. J Antibiot (Tokyo) (2016) 0.75
Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase. J Antimicrob Chemother (2015) 0.75
Addressing the Challenges of Tuberculosis: A Brief Historical Account. Front Pharmacol (2017) 0.75
Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review. Front Immunol (2017) 0.75
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet (2010) 10.21
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem (2000) 8.76
How were new medicines discovered? Nat Rev Drug Discov (2011) 7.00
New uses for old drugs. Nature (2007) 5.86
Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog. J Bacteriol (1996) 4.05
TubercuList--10 years after. Tuberculosis (Edinb) (2010) 2.65
A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One (2009) 2.15
Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol (2007) 1.65
Ibuprofen overdose: 126 cases. Ann Emerg Med (1986) 1.53
Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol Lett (1998) 1.48
Mapping the fMet-tRNA(f)(Met) binding site of initiation factor IF2. EMBO J (2000) 1.30
A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted. Ann Emerg Med (1990) 1.26
Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res (2005) 1.25
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials. Proc Natl Acad Sci U S A (2012) 1.22
The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb) (2009) 1.15
Phospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models. J Pharmacol Exp Ther (2011) 1.15
Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin Exp Immunol (2002) 1.14
Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J Exp Med (2004) 1.14
Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG. Mol Microbiol (2006) 1.11
Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease. Brain Res Brain Res Rev (2005) 1.11
Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. J Antimicrob Chemother (2010) 1.09
Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cell Mol Life Sci (2007) 1.06
An empirical process for the design of high-throughput screening deck filters. J Chem Inf Model (2006) 1.05
Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects. J Pharmacol Exp Ther (2003) 1.04
Nitric oxide modulates interleukin-1beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis. Am J Respir Crit Care Med (2000) 1.03
The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis. PLoS One (2010) 0.99
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrob Agents (2010) 0.97
Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis. J Antimicrob Chemother (2006) 0.96
Ibuprofen: new explanation for an old phenomenon. Biochem Pharmacol (1999) 0.96
Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer. Biochem Pharmacol (2002) 0.95
Drug repositioning in the treatment of malaria and TB. Future Med Chem (2011) 0.94
An overview of clinical pharmacology of Ibuprofen. Oman Med J (2010) 0.92
Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity. J Clin Pathol (1998) 0.90
Reduction of MTT by flavonoids in the absence of cells. Colloids Surf B Biointerfaces (2005) 0.90
Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris. Bioorg Med Chem (2007) 0.88
An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis. J Antimicrob Chemother (2012) 0.87
Antibacterial activity of the anti-inflammatory compound ibuprofen. Lett Appl Microbiol (1995) 0.85
Use of carprofen for the treatment of pain and inflammation in dogs. J Am Vet Med Assoc (1997) 0.84
Probenecid-induced changes in the clearance of carprofen enantiomers: a preliminary study. Clin Pharmacol Ther (1989) 0.83
Ibuprofen: effect on inducible nitric oxide synthase. Brain Res Mol Brain Res (1997) 0.82
Rapid methods for testing inhibitors of mycobacterial growth. Methods Mol Biol (2010) 0.81
Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother (2012) 0.81
Stereospecific pharmacodynamics and pharmacokinetics of carprofen in the dog. J Vet Pharmacol Ther (1994) 0.80
Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. Res Vet Sci (1996) 0.79
5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species. Bioorg Med Chem Lett (2008) 0.78
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med (2014) 5.23
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis (2013) 3.12
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. Am J Respir Crit Care Med (2015) 2.48
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med (2014) 2.42
Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis (2013) 2.16
Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol (2005) 1.94
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis (2012) 1.89
A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol (2003) 1.88
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis (2012) 1.72
Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother (2006) 1.51
Novel PCR-restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates. J Clin Microbiol (2005) 1.44
Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax (2012) 1.42
Evolutionary relationships among strains of Mycobacterium tuberculosis with few copies of IS6110. J Bacteriol (2003) 1.41
Biomarkers of treatment response in clinical trials of novel antituberculosis agents. Lancet Infect Dis (2007) 1.32
Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution? J Antimicrob Chemother (2005) 1.30
Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology (2011) 1.25
Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J Antimicrob Chemother (2005) 1.23
Interaction between FtsZ and FtsW of Mycobacterium tuberculosis. J Biol Chem (2002) 1.19
Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem J (2002) 1.19
Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus. Phytother Res (2005) 1.16
Neurochemical profiles of some novel psychoactive substances. Eur J Pharmacol (2012) 1.15
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J Nat Prod (2008) 1.13
An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid. Nat Commun (2012) 1.11
Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG. Mol Microbiol (2006) 1.11
Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. J Antimicrob Chemother (2010) 1.09
Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode. J Med Chem (2012) 1.09
Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. Biochem J (2005) 1.09
Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry (2004) 1.05
Sesquiterpenes from Warburgia ugandensis and their antimycobacterial activity. Phytochemistry (2005) 1.05
Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatment. J Clin Microbiol (2011) 1.05
A practical guide to measuring mutation rates in antibiotic resistance. Antimicrob Agents Chemother (2008) 1.05
Anti-staphylococcal acylphloroglucinols from Hypericum beanii. Phytochemistry (2006) 1.05
Ostruthin: an antimycobacterial coumarin from the roots of Peucedanum ostruthium. Planta Med (2003) 1.05
Antibacterial iridoid glucosides from Eremostachys laciniata. Phytother Res (2009) 1.02
Brominated diterpenes with antibacterial activity from the red alga Sphaerococcus coronopifolius. J Nat Prod (2008) 1.02
Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts. Microb Drug Resist (2002) 1.02
Dolabellanes with antibacterial activity from the brown alga Dilophus spiralis. J Nat Prod (2010) 1.01
Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J (2013) 1.01
Antibacterial galloylated alkylphloroglucinol glucosides from myrtle (Myrtus communis). J Nat Prod (2006) 1.01
Isoflavanones from Uraria picta and their antimicrobial activity. Phytochemistry (2007) 1.00
Antimalarial compounds from Kniphofia foliosa roots. Phytother Res (2005) 1.00
Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. Phytochemistry (2006) 1.00
Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. J Antimicrob Chemother (2005) 1.00
Antimycobacterial polyacetylenes from Levisticum officinale. Phytother Res (2008) 0.99
Oligomeric acylphloroglucinols from myrtle (Myrtus communis). J Nat Prod (2002) 0.99
Fragment-based hit identification: thinking in 3D. Drug Discov Today (2013) 0.99
Arylamine N-acetyltransferases in mycobacteria. Curr Drug Metab (2008) 0.98
Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents. Tuberculosis (Edinb) (2011) 0.98
ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation. Tuberculosis (Edinb) (2009) 0.98
Tuberculosis: amplification-based clinical diagnostic techniques. Int J Biochem Cell Biol (2003) 0.97
Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus. J Nat Prod (2006) 0.96
Temperature stability of proteins essential for the intracellular survival of Mycobacterium tuberculosis. Biochem J (2009) 0.96
Origins and properties of Mycobacterium tuberculosis isolates in London. J Med Microbiol (2005) 0.96
Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria. Int J Antimicrob Agents (2010) 0.96
Plasma drug activity assay for treatment optimization in tuberculosis patients. Antimicrob Agents Chemother (2011) 0.95
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother (2007) 0.95
Gedunin, a limonoid from Xylocarpus granatum, inhibits the growth of CaCo-2 colon cancer cell line in vitro. Phytother Res (2007) 0.95
Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis. PLoS One (2013) 0.94
Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics. J Antimicrob Chemother (2011) 0.93
Evaluation of a short, on-plate formic acid extraction method for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based identification of clinically relevant yeast isolates. J Clin Microbiol (2014) 0.93
Essential residues for the enzyme activity of ATP-dependent MurE ligase from Mycobacterium tuberculosis. Protein Cell (2010) 0.93
Naturally derived anti-HIV agents. Phytother Res (2005) 0.93
Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. J Antimicrob Chemother (2010) 0.92
Direct detection of heteroresistance in Mycobacterium tuberculosis using molecular techniques. J Med Microbiol (2006) 0.92
The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One (2013) 0.91
Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J Antimicrob Chemother (2008) 0.91
Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania. Tuberc Res Treat (2012) 0.91
The anti-staphylococcal activity of Angelica dahurica (Bai Zhi). Phytochemistry (2004) 0.90
Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases. Bioorg Med Chem Lett (2012) 0.90
Antimycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds. Front Biosci (Landmark Ed) (2012) 0.90
Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. Bioorg Med Chem Lett (2012) 0.89
Iridoid glycosides from Eremostachys glabra. J Nat Prod (2004) 0.88
Assessment of the antibacterial activity of phenylethanoid glycosides from Phlomis lanceolata against multiple-drug-resistant strains of Staphylococcus aureus. J Nat Med (2007) 0.88
Polyisoprenylated benzoylphloroglucinol derivatives from Hypericum sampsonii. J Nat Prod (2007) 0.88
The antimycobacterial constituents of dill (Anethum graveolens). Phytother Res (2005) 0.88
Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris. Bioorg Med Chem (2007) 0.88
Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1). Bioorg Med Chem Lett (2013) 0.88
Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening. J Antimicrob Chemother (2009) 0.88
Competitive binding of a benzimidazole to the histone-binding pocket of the Pygo PHD finger. ACS Chem Biol (2014) 0.87
Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania. J Antimicrob Chemother (2011) 0.87
Prospective evaluation of a complex public health intervention: lessons from an initial and follow-up cross-sectional survey of the tuberculosis strain typing service in England. BMC Public Health (2014) 0.87
Antiprotozoal activity of drimane and coloratane sesquiterpenes towards Trypanosoma brucei rhodesiense and Plasmodium falciparum in vitro. Phytother Res (2010) 0.87
Bioactive pyridine-N-oxide disulfides from Allium stipitatum. J Nat Prod (2009) 0.87
An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis. J Antimicrob Chemother (2012) 0.87
Norlignans, acylphloroglucinols, and a dimeric xanthone from Hypericum chinense. J Nat Prod (2010) 0.87
Antibacterial acylphloroglucinols from Hypericum olympicum. J Nat Prod (2011) 0.87